Park Ha Biological Technology Co., Ltd.
PHHNASDAQConsumer Defensive
$0.39
$-0.00(-0.08%)
Market Cap$9960058
P/E Ratio—
52W High$41.49
52W Low$0.331
Park Ha Biological Technology Co., Ltd. (PHH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PHH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-10 | 2023-10 | 2022-10 | 2021-10 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.38M | $2.46M | $1.92M | $0.93M | $456.00M |
| Cost of Revenue | $0.20M | $0.31M | $0.51M | $0.31M | $0.00M |
| Gross Profit | $2.19M | $2.15M | $1.41M | $0.62M | $456.00M |
| Gross Margin %(computed) | 91.81% | 87.35% | 73.47% | 66.58% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.04M | $0.03M | $0.06M | $0.00M | $0.00M |
| G&A Expenses | $0.81M | $0.48M | $0.71M | $0.75M | $294.00M |
| Total Operating Expenses | $1.39M | $0.97M | $1.21M | $1.12M | ($752.00M) |
| Operating Income | $0.79M | $1.18M | $0.20M | ($0.50M) | ($296.00M) |
| Operating Margin %(computed) | 33.32% | 48.03% | 10.26% | -53.81% | -64.91% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | ($36.00M) |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $73.00M |
| Income Before Tax | $0.79M | $1.18M | $0.19M | ($0.48M) | ($273.00M) |
| Income Tax Expense | $0.31M | $0.33M | ($0.00M) | $0.00M | ($79.00M) |
| Net Income | $0.48M | $0.85M | $0.19M | ($0.48M) | ($194.00M) |
| Net Margin %(computed) | 20.09% | 34.65% | 9.97% | -52.09% | -42.54% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.02 | $0.03 | $0.01 | $-0.02 | $-4.14 |
| Wtd Avg Shares | 26.20M | 26.20M | 26.20M | 26.20M | 46.91M |
| EBITDA | $0.82M | $1.20M | $0.22M | ($0.45M) | ($282.00M) |
| EBITDA Margin %(computed) | 34.27% | 48.84% | 11.50% | -47.80% | -61.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Park Ha Biological Technology Co., Ltd. data
About Park Ha Biological Technology Co., Ltd. (PHH) Income Statement
Park Ha Biological Technology Co., Ltd. (PHH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, PHH reported revenue of $0.00B, gross profit of $0.00B (gross margin 91.81%), and net income of $0.00B — a net profit margin of 20.09%.
Frequently asked questions
PHH · 4 questionsPark Ha Biological Technology Co., Ltd. (PHH) reported revenue of $0.00B for 2024, down 3.1% year-over-year.
PHH revenuePHH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08